Contract Synthesis Services: Why and How to Outsource Chemical Synthesis
Building and maintaining in-house synthetic chemistry capacity is expensive. A fully equipped synthetic chemistry lab — personnel, equipment, reagents, safety infrastructure, QC capability — represents a significant fixed cost that only makes economic sense when it is operating at high utilization across a continuous pipeline of synthesis needs.
For many pharmaceutical companies, biotech startups, materials science firms, and research institutions, that utilization case does not exist continuously. The synthesis requirement spikes during specific project phases and drops during others. Contract synthesis services — outsourcing specific synthesis work to a specialist organization — is the model that addresses this reality.
What Contract Synthesis Services Include
The scope of a contract synthesis engagement varies based on the client’s needs:
- one target structure, defined purity, defined quantity — the most common contract synthesis requestSingle compound synthesis:
- a set of structurally related compounds for SAR studies in drug discovery, produced systematically under consistent conditionsAnalog series synthesis:
- optimization of a synthetic route for scale, cost, or regulatory compliance — often performed ahead of scale-upProcess development synthesis:
- producing a specific synthetic intermediate that the client’s team will use in subsequent in-house chemistry stepsIntermediate synthesis:
- complete synthesis of an active pharmaceutical ingredient from starting materials through final compound, with full regulatory documentationFull API synthesis:
- taking a laboratory synthesis route and producing kilogram or larger quantities while maintaining purity and yieldScale-up synthesis:
→ View Sarchem Labs Contract Synthesis Services
Why Organizations Outsource Chemical Synthesis
Reason | Practical Situation |
No in-house synthetic capacity | Startup or smaller research team with analytical-only lab infrastructure — all synthesis outsourced |
Expertise gap | Target synthesis requires specific expertise (e.g., chiral resolution, organometallic chemistry) not available in-house |
Capacity overflow | In-house team is at capacity on other priorities; specific project synthesis contracted out |
Scale requirement | In-house lab is equipped for milligram-scale; kilogram quantities needed for preclinical work |
Cost efficiency | Contract synthesis at a specialist provider is less expensive than hiring and equipping for an infrequent need |
Speed | Contract provider’s established routes and infrastructure can deliver faster than building a new in-house route |
IP strategy | Some organizations prefer not to build knowledge of specific synthetic routes in-house |
How to Evaluate a Contract Synthesis Partner
Not all contract synthesis providers are equivalent. The evaluation should cover:
Technical Capability
- What chemistry is the provider actually capable of — what classes of reactions, what scales, what characterization methods
- Request examples of comparable complexity from previous work (without requiring IP disclosure from those clients)
- Confirm availability of key equipment: preparative HPLC, chiral columns, high-pressure reactors, inert atmosphere capability
Quality and Documentation
- What analytical methods are used for QC: HPLC (purity), NMR (identity), MS (mass confirmation), Karl Fischer (moisture), residual solvents (GC headspace)
- What documentation format does the COA follow — and can it be customized for your regulatory requirements
- Can the provider supply impurity profiles, genotoxic impurity assessments, or full ICH Q3A/Q3B packages if needed
IP Protection
- Formal NDA/CDA before any compound discussion — non-negotiable for novel structures
- Confirm IP ownership terms: who owns the synthesized compound, the synthetic route, and any novel intermediates developed during synthesis
- US-based providers subject to US IP law — relevant for pharmaceutical and technology companies with US patent portfolios
Timeline and Communication
- What is the realistic timeline including feasibility assessment, starting material sourcing, synthesis, QC, and delivery
- Who is the technical point of contact — and is it a chemist, not only a project manager
The most common contract synthesis failure is a timeline that was agreed without a genuine feasibility assessment. If a provider quotes a 3-week timeline without asking about the synthetic route and starting material availability, that timeline is not based on chemistry — it is a sales estimate. Require written feasibility including route and lead times for key starting materials before approving the timeline.
IP Protection in Contract Synthesis
For pharmaceutical and technology companies, IP protection in a contract synthesis arrangement is as important as the chemistry itself. Key terms to establish before work begins:
- Compound ownership: the synthesized compound and all characterized data belong to the client
- Route ownership: the specific synthetic route developed for the client’s compound is the client’s IP
- Confidentiality: the provider does not disclose target structures, synthetic approaches, or the existence of the engagement
- Background IP: provider retains rights to general chemistry knowledge and methods not specific to the client’s project
- Publication restrictions: provider does not publish or patent findings from the engagement without client consent
Why Sarchem Labs for Contract Synthesis
Sarchem Labs has provided contract synthesis services for 25+ years to pharmaceutical companies, CROs, universities, and government institutions. For organizations evaluating an outsource chemistry partner:
- USA-based team — IP protection under US law, no overseas exposure of novel structures
- Full analytical package: HPLC, NMR, MS, Karl Fischer, residual solvents per lot
- Flexible scope: individual compound synthesis through multi-step programs
- Formal NDA available before any project discussion
- Dedicated technical point of contact — a chemist, not a sales interface
→ Request a Contract Synthesis Quote
→ Contact Sarchem Labs to Discuss Your Synthesis Project
Conclusion
Outsourcing chemical synthesis to a qualified contract provider is often the most efficient path for organizations that need specific compounds synthesized without building or maintaining permanent in-house synthesis infrastructure. The evaluation criteria — technical capability, QC standards, IP protection terms, and realistic timeline assessment — are what separate a successful engagement from an expensive delay.
Ready to Outsource Your Chemical Synthesis? Sarchem Labs — USA-Based Contract Synthesis With Full Documentation. Request a Quote Today.
Request a Quote: https://www.sarchemlabs.com/quote/
FAQ
What is contract chemical synthesis?
Contract synthesis is the outsourcing of specific chemical synthesis work to a third-party specialist organization under a formal agreement covering scope, timeline, cost, IP ownership, and quality specifications.
How is contract synthesis different from buying a catalog chemical?
Catalog chemicals are pre-made compounds available for immediate purchase. Contract synthesis is used when the needed compound does not exist in a catalog, requires a purity or scale not commercially available, or requires a structural modification not commercially offered.
Who owns the compound synthesized under a contract synthesis agreement?
IP ownership should be explicitly defined in the contract before work begins. Standard terms assign compound ownership and the associated synthetic route to the client. Confirm this in writing — do not assume.
Can Sarchem Labs synthesize pharmaceutical intermediates and APIs?
Yes. Sarchem Labs synthesizes pharmaceutical intermediates and APIs with full analytical characterization documentation. Contact the technical team to discuss specific requirements and documentation needs for your application.